New Antimicrobial and Anticancer Compounds from Imidazo[2,1-b][1,3,4]thiadiazoles
Author Information
Author(s): Dwarakanath Deepika, Nayak Yogeesha N., Kulal Ananda, Pandey Samyak, Pai K Sreedhara Ranganath, Gaonkar Santosh L.
Primary Institution: Manipal Academy of Higher Education, Manipal
Hypothesis
The study aims to develop novel imidazo[2,1-b][1,3,4]thiadiazole derivatives with potential antimicrobial and anticancer properties.
Conclusion
The study successfully synthesized and evaluated five new imidazo[2,1-b][1,3,4]thiadiazole derivatives, with one showing significant anticancer activity.
Supporting Evidence
- All derivatives showed good antimicrobial activity against four microorganisms.
- Derivative 3c exhibited the highest anticancer activity with an IC50 value of 35.81 μM.
- Three derivatives showed better inhibition than the standard drug cisplatin.
Takeaway
Scientists created new compounds that might help fight infections and cancer, and one of them worked really well against cancer cells.
Methodology
The compounds were synthesized, characterized using various spectroscopic methods, and their antimicrobial and anticancer activities were evaluated through minimum inhibitory concentration and cytotoxicity assays.
Limitations
The study does not provide extensive in vivo data or long-term efficacy results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website